Ty21a Typhoid Vaccine
Showing 1 - 25 of 9,776
Intestinal Permeability, Inflammation, Vaccine Trial in Davis (Vivotif Typhoid Oral Vaccine, Aspirin (Positive Control))
Active, not recruiting
- Intestinal Permeability
- +3 more
- Vivotif Typhoid Oral Vaccine
- Aspirin (Positive Control)
-
Davis, CaliforniaUSDA, ARS, Western Human Nutrition Research Center
Jan 10, 2023
Inflammation, Vaccine, Intestinal Permeability Trial in Davis (Inulin, Maltodextrin, Ty21a Typhoid Fever Vaccine)
Recruiting
- Inflammation
- +3 more
- Inulin
- +2 more
-
Davis, CaliforniaUSDA, ARS, Western Human Nutrition Research Center
Nov 29, 2022
Influenza, Hepatitis A, Typhoid Trial in Stanford (Fluzone® quadrivalent, Fluzone High Dose, Fluad)
Active, not recruiting
- Influenza
- +3 more
- Fluzone® quadrivalent
- +5 more
-
Stanford, CaliforniaStanford LPCH Vaccine Program
Dec 12, 2022
Typhoid Vaccination Trial in Baltimore (Vivotif Typhoid Oral Vaccine)
Active, not recruiting
- Typhoid Vaccination
- Vivotif Typhoid Oral Vaccine
-
Baltimore, MarylandUniverstiy of Maryland, Baltimore, Center for Vaccine Developmen
Oct 18, 2021
Risk Reduction Trial in Baltimore (Vivotif Typhoid Oral Vaccine)
Recruiting
- Risk Reduction
- Vivotif Typhoid Oral Vaccine
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
Oct 12, 2021
Typhoid Fever, Enteric Fever, Typhoid Trial in Oxford (Vaccine (excipients only), Ty21a, M10ZH09 vaccine)
Active, not recruiting
- Typhoid Fever
- +2 more
- Vaccine placebo (excipients only)
- +2 more
-
Oxford, United KingdomOxford Vaccine Group, Centre for Clinical Vaccinology and Tropic
Dec 7, 2020
Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)
Not yet recruiting
- Iron Deficiency Anemia
- Iron-fortified cookies
- +3 more
- (no location specified)
Aug 30, 2023
Typhoid Trial in Dhaka (Typhoid Vi polysaccharide-diphtheria toxoid conjugate vaccine (Vi-DT))
Not yet recruiting
- Typhoid
- Typhoid Vi polysaccharide-diphtheria toxoid conjugate vaccine (Vi-DT)
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Jul 25, 2022
Typhoid Fever Trial (TYP04A Low Dose without adjuvant investigational vaccine, TYP04B Full Dose without adjuvant investigational
Not yet recruiting
- Typhoid Fever
- TYP04A Low Dose without adjuvant investigational vaccine
- +5 more
- (no location specified)
Nov 4, 2022
Salmonella Infections Trial (biological, combination product, drug, other)
Not yet recruiting
- Salmonella Infections
- Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose
- +10 more
- (no location specified)
Jul 27, 2022
Monkeypox Trial in Nigeria (Bavarian Nordic smallpox vaccine, Typhoid VI Polysaccharide Vaccine Injectable Solution)
Not yet recruiting
- Monkeypox
- Bavarian Nordic smallpox vaccine
- Typhoid VI Polysaccharide Vaccine Injectable Solution
-
Abuja, Nigeria
- +7 more
Feb 16, 2023
Typhoid, Cholera, Measles Trial (Oral Cholera Vaccine (OCV), Typhoid Conjugate Vaccine (TCV), Measles and Rubella (MR))
Not yet recruiting
- Typhoid
- +3 more
- Oral Cholera Vaccine (OCV)
- +2 more
- (no location specified)
Mar 5, 2023
Typhoid Trial in Blantyre (Vi-Typhoid Conjugate Vaccine (Vi-TCV), Meningococcal A Conjugate Vaccine (MCV-A))
Active, not recruiting
- Typhoid
- Vi-Typhoid Conjugate Vaccine (Vi-TCV)
- Meningococcal A Conjugate Vaccine (MCV-A)
-
Blantyre, MalawiMalawi Liverpool Wellcome Trust Clinical Research Programme, Que
Feb 15, 2022
Typhoid Fever Trial in Kumasi (Vi-TT, MCV-A vaccine)
Enrolling by invitation
- Typhoid Fever
- Vi-TT
- MCV-A vaccine
-
Kumasi, Ashanti, GhanaKwame Nkrumah University of Science and Technology
Dec 8, 2021
Typhoid Fever Trial in Kisantu (Vi-TT)
Not yet recruiting
- Typhoid Fever
- Vi-TT
-
Kisantu, Congo, The Democratic Republic of theHôpital Saint Luc de Kisantu
Nov 12, 2021
Non Muscle Invasive Bladder Cancer Trial in Lausanne (Ty21a)
Recruiting
- Non Muscle Invasive Bladder Cancer
- Ty21a
-
Lausanne, Vaud, SwitzerlandDpt Urology- CHUV
Apr 27, 2021
Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India
Completed
- Enteric Fever
- +2 more
- Typhoid Conjugate Vaccine
-
Navi Mumbai, India
- +5 more
Sep 30, 2021
Salmonella Typhi Infection Trial in Oxford (Salmonella Typhi (S. Typhi))
Unknown status
- Salmonella Typhi Infection
- Salmonella Typhi (S. Typhi)
-
Oxford, Oxfordshire, United KingdomOxford Vaccine Group, Centre for Clinical Vaccinology and Tropic
Dec 9, 2021
Typhoid Trial in Ouagadougou (Vi-Typhoid Conjugate Vaccine (Vi-TCV), Inactivated Poliovirus Vaccine (IPV))
Completed
- Typhoid
- Vi-Typhoid Conjugate Vaccine (Vi-TCV)
- Inactivated Poliovirus Vaccine (IPV)
-
Ouagadougou, Burkina FasoGroupe de Recherche Action en Santé (GRAS)
Jul 8, 2021
Cardiovascular Diseases Trial in London (Typhoid vaccine, Concentrate beetroot Juice, Concentrate beetroot Juice (Placebo))
Completed
- Cardiovascular Diseases
- Typhoid vaccine
- +2 more
-
London, United KingdomWilliam Harvey Research Institute, Barts and The London School o
Jul 19, 2022
Typhoid Fever Trial in Cavite, Quezon City (EuTCV (Vi-CRM Typhoid conjugate vaccine), Typbar-TCV)
Completed
- Typhoid Fever
- EuTCV (Vi-CRM Typhoid conjugate vaccine)
- Typbar-TCV
-
Cavite, Philippines
- +1 more
Oct 6, 2021
Meningococcal Infection (Healthy Volunteers) Trial in Middelburg (Meningococcal Polysaccharide (Serogroups A, C, Y, and W)
Recruiting
- Meningococcal Infection (Healthy Volunteers)
- Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
- +11 more
-
Middelburg, South AfricaInvestigational Site Number: 7100001
Apr 4, 2023
Healthy Women of Child Bearing Potential Trial (R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline)
Not yet recruiting
- Healthy Women of Child Bearing Potential
- R21/Matrix-M1
- +2 more
- (no location specified)
Oct 10, 2023
Typhoid Trial in Alabang (Vi-DT, FluQuadri™, 0.9% sodium chloride isotonic solution)
Completed
- Typhoid
- Vi-DT
- +2 more
-
Alabang, Muntinlupa City, PhilippinesResearch Institute for Tropical Medicine(RITM)
Aug 26, 2021
Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)
Not yet recruiting
- Malaria, Plasmodium Falciparum
- Matrix-M with RH5.2 VLP and/or R21
- (no location specified)
Oct 21, 2022